Testing effectiveness (Phase 2)Study completedNCT00136461
What this trial is testing
All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 40